TMO Mar 2025 860.000 call
| Previous close | 0.9900 |
| Open | 3.4600 |
| Bid | 0.0000 |
| Ask | 4.3000 |
| Strike | 860.00 |
| Expiry date | 2025-03-21 |
| Day's range | 0.9900 - 3.4600 |
| Contract range | N/A |
| Volume | |
| Open interest | 15 |
ZacksMYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
BloombergDealmaker Paul Parker Joins Health VC Firm Flagship Pioneering
(Bloomberg) -- Paul Parker, a former mergers and acquisitions banker turned health-care executive, is joining Flagship Pioneering Inc., the investment firm that created Covid-vaccine maker Moderna Inc.Most Read from BloombergUrban Heat Stress Is Another Disparity in the World’s Most Unequal NationChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilShould Evictions Be Banned After Hurricanes and Climate Disasters?From Cleveland to Chicago, NFL Teams Dream of Domed StadiumsSingapore Ends
